The Promyelocytic Leukemia Zinc Finger Protein Affects Myeloid Cell Growth, Differentiation, and Apoptosis

REFERENCES

• Ahn, M. J., K. Nason-Burchenal, M. M. Moasser, and E. Dmitrovsky 1995. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML. Oncogene 10: 2307–2314.
   PubMed Web of Science ®Google Scholar
• Albagli, O., P. Dhordain, C. Deweindt, G. Lecocq, and D. Leprince 1995. The BTB/POZ domain: a new protein-protein interaction motif common to DNA- and actin-binding proteins. Cell Growth Differ. 6: 1193–1198.
   PubMedGoogle Scholar
• Anderson, S. A., P. M. Carrol, and F. Lee 1990. Abrogation of IL-3 dependent growth requires a functional v-src gene product: evidence for an autocrine growth cycle. Oncogene 5: 317–325.
   PubMed Web of Science ®Google Scholar
• Baffy, G., T. Miyashita, J. R. Williamson, and J. C. Reed 1993. Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production. J. Biol. Chem. 268: 6511–6519.
   PubMed Web of Science ®Google Scholar
• Bagby, G. J. 1994. Hematopoiesis The molecular basis of blood diseases. W. B. In: Stamatoyannopoulos, G., A. W. Nienhaus, P. W. Majerus, and H. Varmus71–103Saunders, Philadelphia, Pa.
   Google Scholar
• Bardwell, V. J., and R. Treisman 1994. The POZ domain: a conserved protein-protein interaction motif. Genes Dev. 8: 1664–1677.
   PubMed Web of Science ®Google Scholar
• Challita, P. M., and D. B. Kohn 1994. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc. Natl. Acad. Sci. USA 91: 2567–2571.
   PubMed Web of Science ®Google Scholar
• Chang, K. S., Y. H. Fan, M. Andreeff, J. Liu, and Z. M. Mu 1995. The PML gene encodes a phosphoprotein associated with the nuclear matrix. Blood 85: 3646–3653.
   PubMed Web of Science ®Google Scholar
• Chen, S. J., A. Zelent, J. H. Tong, H. Q. Yu, Z. Y. Wang, J. Derre, R. Berger, S. Waxman, and Z. Chen 1993. Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia. J. Clin. Invest. 91: 2260–2267.
   PubMed Web of Science ®Google Scholar
• Chen, Z., N. J. Brand, A. Chen, S. J. Chen, J. H. Tong, Z. Y. Wang, S. Waxman, and A. Zelent 1993. Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J. 12: 1161–1167.
   PubMed Web of Science ®Google Scholar
• Chomienne, C., P. Fenaux, and L. Degos 1996. Retinoid differentiation therapy in promyelocytic leukemia. FASEB J. 10: 1025–1030.
   PubMed Web of Science ®Google Scholar
• Cook, M., A. Gould, N. Brand, J. Davies, P. Strutt, R. Shaknovich, J. Licht, S. Waxman, Z. Chen, S. Gluecksohn-Waelsch, R. Krumlauf, and A. Zelent 1995. Expression of the zinc-finger gene PLZF at rhombomere boundaries in the vertebrate hindbrain. Proc. Natl. Acad. Sci. USA 92: 2249–2253.
   PubMedGoogle Scholar
• de Thé, H., C. Chomienne, M. Lanotte, L. Degos, and A. Dejean 1990. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 347: 558–561.
   PubMed Web of Science ®Google Scholar
• Dong, S., J. Zhu, A. Reid, P. Strutt, F. Guidez, H. J. Zhong, Z. Y. Wang, J. Licht, S. Waxman, C. Chomienne, Z. Chen, A. Zelent, and S. J. Chen 1996. Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion protein. Proc. Natl. Acad. Sci. USA 93: 3624–3629.
   PubMed Web of Science ®Google Scholar
• Dyck, J. A., G. G. Maul, Miller W. H., Jr., J. D. Chen, A. Kakizuka, and R. M. Evans 1994. A novel macromolecular structure is a target of the promyelocytic-retinoic acid receptor oncoprotein. Cell 76: 333–343.
   PubMed Web of Science ®Google Scholar
• Evan, G. I., A. H. Wyllie, C. S. Gilbert, T. D. Littlewood, H. Land, M. Brooks, C. M. Waters, L. Z. Penn, and D. C. Hancock 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119–128.
   PubMed Web of Science ®Google Scholar
• Goddard, A., J. Borrow, P. Freemont, and E. Solomon 1991. Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science 254: 1371–1374.
   PubMed Web of Science ®Google Scholar
• Grignani, F., S. De Metteis, C. Nervi, L. Tomassoni, V. Gelmetti, M. Cioce, M. Fanelli, M. Ruthardt, F. F. Ferrara, I. Zamir, C. Seiser, F. Grignani, M. A. Lazar, S. Minucci, and P. G. Pelicci 1998. Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukemia. Nature 391: 815–818.
   PubMed Web of Science ®Google Scholar
• Grignani, F., M. Fagioli, M. Alcalay, L. Longo, P. P. Pandolfi, E. Donti, A. Biondi, F. Lo Coco, F. Grignani, and P. G. Pelicci 1994. Acute promyelocytic leukemia: from genetics to treatment. Blood 83: 10–25.
   PubMed Web of Science ®Google Scholar
• Guidez, F., W. Huang, J. H. Tong, C. Dubois, N. Balitrand, S. Waxman, J. L. Michaux, P. Martiat, L. Degos, Z. Chen, and C. Chomienne 1994. Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patient. Leukemia 8: 312–317.
   PubMed Web of Science ®Google Scholar
• Guidez, F., S. Ivins, J. Zhu, M. Söderström, S. Waxman, and A. Zelent 1998. Reduced retinoic acid sensitivities of nuclear receptor co-repressor binding to PML- and PLZF-RARα underline molecular pathogenesis and treatment of acute promyelocytic leukemia. Blood 91: 2634–2642.
   PubMed Web of Science ®Google Scholar
• He, L.-Z., F. Guidez, C. Triboli, D. Peruzzi, M. Ruthardt, A. Zelent, and P. P. Pandolfi 1998. Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL. Nat. Genet. 18: 126–135.
   PubMed Web of Science ®Google Scholar
• Hong, S. H., G. David, C. W. Wong, A. Dejean, and M. L. Privalsky 1997. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARα) and PLZF-RARα oncoproteins associated with acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA 94: 9028–9033.
   PubMed Web of Science ®Google Scholar
• Ihle, J. N., B. A. Witthuhn, F. W. Quelle, K. Yamamoto, W. E. Thierfelder, B. Kreider, and O. Silvennoinen 1994. Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem. Sci. 4: 222–227.
   Google Scholar
• Kakizuka, A., Miller, W. H.Jr., K. Umesono, Warrell R. P., Jr., S. R. Frankel, V. V. Murty, E. Dmitrovsky, and R. M. Evans 1991. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66: 663–674.
   PubMed Web of Science ®Google Scholar
• Kimchi, A. 1992. Cytokine triggered molecular pathways that control cell cycle arrest. J. Cell. Biochem. 50: 1–9.
   PubMedGoogle Scholar
• Kishimoto, T., T. Taga, and S. Akira 1994. Cytokine signal transduction. Cell 76: 253–262.
   PubMed Web of Science ®Google Scholar
• Koken, M. H., G. Linares-Cruz, F. Quignon, A. Viron, M. K. Chelbi-Alix, J. Sobczak-Thepot, L. Juhlin, L. Degos, F. Calvo, and H. de Thé 1995. The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene 10: 1315–1324.
   PubMed Web of Science ®Google Scholar
• Koken, M. H. M., F. Puvion-Dutilleul, M. C. Guillemin, A. Viron, G. Linares-Cruz, N. Stuurman, L. de Jong, C. Szostecki, F. Calvo, C. Chomienne, L. Degos, E. Puvion, and H. de Thé 1994. The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J. 13: 1073–1083.
   PubMed Web of Science ®Google Scholar
• Koken, M. H. M., A. Reid, F. Quignon, M. K. Chelbi-Alix, J. M. Davies, J. H. S. Kabarowski, J. Zhu, S. Dong, S. Chen, Z. Chen, C. C. Tan, J. Licht, S. Waxman, H. de Thé, and A. Zelent 1997. Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies. Proc. Natl. Acad. Sci. USA 94: 10255–10260.
   PubMed Web of Science ®Google Scholar
• Kreider, B. L., P. D. Phillips, M. B. Prystowsky, N. Shirsat, J. H. Pierce, R. Tushinski, and G. Rovera 1990. Induction of the granulocyte-macrophage colony-stimulating factor (CSF) receptor by granulocyte CSF increases the differentiative options of a murine hematopoietic progenitor cell. Mol. Cell. Biol. 10: 4846–4853.
   PubMedGoogle Scholar
• Labbaye, C., and J. D. Licht. Unpublished data.
   Google Scholar
• Lavau, C., and J. D. Licht. Unpublished data.
   Google Scholar
• Leroy, P., A. Krust, A. Zelent, C. Mendelsohn, J.-M. Garnier, P. Kastner, A. Dierich, and P. Chambon 1991. Multiple isoforms of the mouse retinoic acid receptor α are generated by alternative splicing and differential induction by retinoic acid. EMBO J. 10: 59–69.
   PubMed Web of Science ®Google Scholar
• Li, J.-Y., M. A. English, H. J. Ball, P. L. Yeyati, S. Waxman, and J. D. Licht 1997. Sequence-specific DNA binding and transcriptional regulation by the promyelocytic leukemia zinc finger protein. J. Biol. Chem. 272: 22447–22455.
   PubMedGoogle Scholar
• Licht, J. D., C. Chomienne, A. Goy, A. Chen, A. A. Scott, D. R. Head, J. L. Michaux, Y. Wu, A. DeBlasio, Miller W. H., Jr., A. D. Zelenetz, C. L. Wilman, Z. Chen, S.-J. Chen, A. Zelent, E. Macintyre, A. Veil, J. Cortes, H. Kantarjian, and S. Waxman 1995. Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17). Blood 85: 1083–1094.
   PubMed Web of Science ®Google Scholar
• Licht, J. D., R. Shaknovich, M. A. English, A. Melnick, J. Y. Li, J. C. Reddy, S. Dong, S. J. Chen, A. Zelent, and S. Waxman 1996. Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-alpha chimera generated in t(11;17)-associated acute promyelocytic leukemia. Oncogene 12: 323–336.
   PubMed Web of Science ®Google Scholar
• Liebermann, D. A., B. Hoffman, and R. A. Steinman 1995. Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene 11: 199–210.
   PubMed Web of Science ®Google Scholar
• Lin, E., A. Orlofsky, H.-G. Wang, J. C. Reed, and M. B. Prystowsky 1996. A1, a Bcl-2 family member, prolongs survival and permits myeloid differentiation. Blood 87: 983–992.
   PubMedGoogle Scholar
• Lin, R. J., L. Nagy, S. Inoue, W. Shao, Miller W. H., Jr., and R. M. Evans 1998. Role of the histone deacetylase complex in acute promyelocytic leukemia. Nature 391: 811–814.
   PubMed Web of Science ®Google Scholar
• Mavilio, F., B. L. Kreider, M. N. Valtieri, G. Naso, N. Shirsat, D. Venturelli, E. P. Reddy, and G. Rovera 1989. Alteration of growth and differentiation factors response by Kirsten and Harvey sarcoma viruses in the IL-3-dependent murine hematopoietic cell line 32DCL3(G). Oncogene 4: 301–308.
   PubMedGoogle Scholar
• Moore, M. 1991. Clinical implications of positive and negative hematopoietic stem cell regulators. Blood 78: 1–19.
   PubMed Web of Science ®Google Scholar
• Morgenstern, P. J., and H. Land 1990. Advanced mammalian gene transfer: high titer retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18: 3587–3596.
   PubMed Web of Science ®Google Scholar
• Mu, Z.-M., K.-V. Chin, J.-H. Liu, G. Lozano, and K.-S. Chang 1994. PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol. Cell. Biol. 14: 6858–6867.
   PubMed Web of Science ®Google Scholar
• Naumovski, L., and M. L. Cleary 1994. Bcl2 inhibits apoptosis associated with terminal differentiation of HL-60 myeloid leukemia cells. Blood 83: 2261–2267.
   PubMed Web of Science ®Google Scholar
• Numoto, M., O. Niwa, J. Kaplan, K. K. Wong, K. Merrell, K. Kamiya, K. Yanagihara, and K. Calame 1993. Transcriptional repressor ZF5 identifies a new conserved domain in zinc finger proteins. Nucleic Acids Res. 21: 3767–3775.
   PubMed Web of Science ®Google Scholar
• Ogawa, M. 1993. Differentiation and proliferation of hematopoietic stem cells. Blood 81: 2844–2853.
   PubMed Web of Science ®Google Scholar
• Park, J. R., K. Robertson, D. D. Hickstein, S. Tsai, D. M. Hockenbery, and S. J. Collins 1994. Dysregulated bcl-2 expression inhibits apoptosis but not differentiation of retinoic acid-induced HL-60 granulocytes. Blood 84: 440–445.
   PubMed Web of Science ®Google Scholar
• Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90: 8392–8396.
   PubMed Web of Science ®Google Scholar
• Pines, J., and T. Hunter 1995. Cyclin-dependent kinases: an embarassment of riches? Cell cycle control. In: Hutchison, C., and D. Glover144–176IRL Press, Oxford, United Kingdom.
   Google Scholar
• Redner, R. L., S. J. Corey, and E. A. Rush 1997. Differentiation of t(5;17) variant acute promyelocytic leukemic blasts by all-trans retinoic acid. Leukemia 11: 1014–1016.
   PubMed Web of Science ®Google Scholar
• Redner, R. L., E. A. Rush, S. Faas, W. A. Rudert, and S. J. Corey 1996. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. Blood 87: 882–886.
   PubMed Web of Science ®Google Scholar
• Reid, A., A. Gould, N. Brand, M. Cook, P. Strutt, J. Li, J. Licht, S. Waxman, R. Krumlauf, and A. Zelent 1995. Leukemia translocation gene, PLZF, is expressed with a speckled nuclear pattern in early hematopoietic progenitors. Blood 86: 4544–4552.
   PubMedGoogle Scholar
• Rovera, G., M. Valtieri, F. Mavilio, and E. P. Reddy 1987. Effect of Abelson murine leukemia virus on granulocytic differentiation and interleukin-3 dependence of a murine progenitor cell line. Oncogene 1: 29–35.
   PubMed Web of Science ®Google Scholar
• Ruthardt, M., U. Testa, C. Nervi, P. F. Ferrucci, F. Grignani, E. Puccetti, F. Grignani, C. Peschle, and P. G. Pelicci 1997. Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor alpha (RARα) and PLZF-RARα fusion proteins on retinoic acid signalling. Mol. Cell. Biol. 17: 4859–4869.
   PubMed Web of Science ®Google Scholar
• Shaknovich, R., S. Ivers, A. Zelent, and J. D. Licht. Unpublished data.
   Google Scholar
• Shan, B., and W.-H. Lee 1994. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol. 14: 8166–8173.
   PubMedGoogle Scholar
• Shimada, Y., G. Migliaccio, H. Shaw, and A. R. Migliaccio 1993. Erythropoietin-specific cell cycle progression in erythroid subclones of the interleukin-3-dependent cell line 32d. Blood 81: 935–941.
   PubMedGoogle Scholar
• Sitterlin, D., P. Tiollais, and C. Transy 1997. The RARα-PLZF chimera associated with acute promyelocytic leukemia has retained a sequence-specific DNA binding domain. Oncogene 14: 1067–1074.
   PubMed Web of Science ®Google Scholar
• Soddu, S., G. Blandino, R. Scardigli, R. Martinelli, M. G. Rizzo, M. Crescenzi, and A. Sacchi 1996. Wild-type p53 induces diverse effects in 32D cells expressing different oncogenes. Mol. Cell. Biol. 16: 487–495.
   PubMedGoogle Scholar
• Spangrude, G. J., S. Heimfeld, and I. L. Weissman 1988. Purification and characterization of mouse hematopoietic stem cells. Science 241: 58–62.
   PubMed Web of Science ®Google Scholar
• Tenen, D. G., R. Hromas, J. D. Licht, and D. E. Zhang 1997. Transcription factors, normal myeloid development, and leukemia. Blood 90: 489–519.
   PubMed Web of Science ®Google Scholar
• van Engeland, M., F. C. Ramaekers, B. Schutte, and C. P. Reutelingsperger 1996. A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry 24: 131–139.
   PubMedGoogle Scholar
• Vanhaesebroeck, B., J. C. Reed, D. De Valck, J. Grooten, T. Miyashita, S. Tanaka, R. Beyaert, F. Van Roy, and W. Fiers 1993. Effect of bcl-2 proto-oncogene expression on cellular sensitivity to tumor necrosis factor-mediated cytotoxicity. Oncogene 8: 1075–1081.
   PubMed Web of Science ®Google Scholar
• Warrell, R. P.Jr., H. de Thé, Z. Y. Wang, and L. Degos 1993. Acute promyelocytic leukemia. N. Engl. J. Med. 329: 177–189.
   PubMed Web of Science ®Google Scholar
• Weis, K., S. Rambaud, C. Lavau, J. Jansen, T. Carvalho, M. Carmo-Fonseca, A. Lamond, and A. Dejean 1994. Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell 76: 345–356.
   PubMed Web of Science ®Google Scholar
• Wells, R. A., C. Catzavelos, and S. Kamel-Reid 1997. Fusion of the retinoic acid receptor α to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukemia. Nat. Genet. 17: 109–113.
   PubMed Web of Science ®Google Scholar
• Wells, R. A., J. L. Hummel, A. De Koven, A. Zipursky, M. Kirby, I. Dube, and S. Kamel-Reid 1996. A new variant translocation in acute promyelocytic leukaemia: molecular characterization and clinical correlation. Leukemia 10: 735–740.
   PubMedGoogle Scholar
• Yang, E., and S. J. Korsmeyer 1996. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 88: 386–401.
   PubMed Web of Science ®Google Scholar
• Ye, B. H., F. Lista, F. Lo Coco, D. M. Knowles, K. Offit, R. S. Chaganti, and R. Dalla-Favera 1993. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 262: 747–750.
   PubMed Web of Science ®Google Scholar
• Yen, A., D. Brown, and J. Fishbaugh 1987. Precommitment states induced during HL-60 myeloid differentiation: possible similarities of retinoic acid- and DMSO-induced early events. Exp. Cell Res. 173: 80–84.
   PubMedGoogle Scholar
• Yen, A., M. Forbes, G. DeGala, and J. Fishbaugh 1987. Control of HL-60 cell differentiation lineage specificity, a late event occurring after precommitment. Cancer Res. 47: 129–134.
   PubMed Web of Science ®Google Scholar
• Yeyati, P. L., R. Shaknovich, and J. D. Licht. Unpublished data.
   Google Scholar